[185 Pages Report] The Infection Surveillance Solution Market size was estimated at USD 768.47 million in 2023 and expected to reach USD 867.99 million in 2024, at a CAGR 13.36% to reach USD 1,849.73 million by 2030.
Infection surveillance solutions predict resident and healthcare staff infections in real-time and control possible epidemics. The solutions record infection data and turn it into actionable insights for strategic planning to prevent potential infections. The instances of hospital-acquired infections in adults grow the market. However, there is a need to employ cost-effective measures to adopt infection surveillance tools by small-scale laboratories and healthcare facilities. The ongoing innovations based on artificial intelligence and data analytics are improving the efficiency of infection surveillance solutions by combining them with electronic medical records.
In the Americas, Government agencies such as the Centers for Disease Control and Prevention (CDC) manages infection surveillance through secure, internet-based surveillance systems of national healthcare safety networks. The increasing number of patients suffering from infectious diseases and the need for antimicrobial tracking surged the need for infection surveillance solutions in the market. The market players in the Americas are advancing innovative technologies for infection surveillance based on artificial intelligence and data science tools. Public and private sector is investing in research and development of innovative technologies in infection surveillance in the region.
The Middle East and Africa's market is anticipated to boost due to growing healthcare sector in the region. The Asia-Pacific region is expected to raise the market demand due to the increasing number of healthcare facilities. The growing awareness about antimicrobial resistance and hospital-acquired infections is the rising adoption of infection surveillance solutions in the region.
The market dynamics represent an ever-changing landscape of the Infection Surveillance Solution Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
- Market Drivers
- Growing geriatric population coupled with increasing incidences of chronic diseases
- Increasing prevalence of hospital-acquired infections (HAIs)
- Rising adoption of antimicrobial stewardship programs
- Market Restraints
- High cost associated with the deployment of infection surveillance solutions
- Market Opportunities
- Development of fully automated infection surveillance solution systems with the integration of electronic medical records
- Rapid emergence of cloud based infection surveillance solutions
- Market Challenges
- Limited availability of skilled healthcare IT professional
The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Infection Surveillance Solution Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Infection Surveillance Solution Market.
The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Infection Surveillance Solution Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.
The value chain of the Infection Surveillance Solution Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.
The pricing analysis comprehensively evaluates how a product or service is priced within the Infection Surveillance Solution Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Infection Surveillance Solution Market.
The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Infection Surveillance Solution Market.
The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Infection Surveillance Solution Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.
The trade analysis of the Infection Surveillance Solution Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.
The regulatory framework analysis for the Infection Surveillance Solution Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Infection Surveillance Solution Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Infection Surveillance Solution Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Orbis Protect Acquires Secure Site UK to Further Enhance Their Security Solutions & Service Offering.
Staying ahead of potential security threats is critical for any organization. Orbis Protect, a leading security solutions company, has recently acquired Secure Site UK to further enhance their security offerings. This acquisition underscores the company's commitment to providing cutting-edge security solutions to its clients. With Orbis Protect's expertise and Secure Site UK's infection surveillance solutions, organizations can ensure they have proactive measures in place to safeguard their facilities and employees. As businesses adapt to the ever-changing security landscape, Orbis Protect remains at the forefront of providing innovative solutions to help minimize risk and increase peace of mind. [Published On: 2023-03-01]
West Hartford-Bloomfield Health District Coalition Against Healthcare-Acquired Infections Team Recognized as NACCHO Infection Prevention and Control Champion.
As the importance of infection prevention and control continues to be emphasized in healthcare settings, the need for effective surveillance solutions only grows. With the rise of new infectious diseases and the constant evolution of existing ones, it is critical that healthcare facilities have the most advanced tools to track, monitor, and manage infections. The market for infection surveillance solutions is highly competitive and constantly evolving, with new technologies and innovations emerging regularly. It is essential for healthcare organizations to work with trusted partners in order to stay ahead of the curve and ensure the safety of their patients and staff. With so much at stake, selecting the right infection surveillance solution is an important decision that requires careful consideration and due diligence. [Published On: 2023-02-27]
American Firm Named as Sole Supplier For £20m (USD 24.06 Million) Framework.
In the ever-evolving field of patient safety, infection surveillance is a critical tool for healthcare providers. That's why news of a £20m framework for Infection Surveillance Solutions is so important. Recently announced by NHS Shared Business Services, the framework has selected an American company to be the exclusive supplier for this crucial technology. While some may be wary of an overseas supplier, the chosen firm has an impressive track record of providing accurate and reliable infection surveillance solutions. With patient safety at the forefront of healthcare concerns, this framework will undoubtedly have a positive impact on the delivery of care in the UK. [Published On: 2023-02-21]
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Infection Surveillance Solution Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
The report delves into recent significant developments in the Infection Surveillance Solution Market, highlighting leading vendors and their innovative profiles. These include Securitas Healthcare, LLC., 3M Company, Datlowe, s.r.o., Health Matrix., Altarum, CenTrak, Inc., Vitalacy Inc., BioVigil Healthcare Systems, Inc., PointClickCare, International Business Machines Corporation, DNV AS, Vizzia Technologies, Ecolab Inc., Inovalon, Conduent, Inc., Premier Inc., Clinsys, Inc., Ibhar Technologies Pvt Ltd, Cardinal Health Inc., Gunnebo Entrance Control Ltd., Oracle Corporation, Medexter Healthcare GmbH, RLDatix, VigiLanz Corporation, Vecna Technologies, Inc., Baxter International, Inc., Thermo Fisher Scientific Inc., Wolters Kluwer N.V., Strategic Solutions Group, bioMérieux SA, and Becton, Dickinson and Company.
This research report categorizes the Infection Surveillance Solution Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product
- Services
- Implementation Services
- Product Support & Maintainnace Services
- Training & Consulting Services
- Software
- Antimicrobial Monitoring & Control
- Infection Surveillance
- Laboratory surveillance
- Surgical surveillance & patient monitoring
- Outbreak Management
- Isolation Management
- Potential Outbreak Alert
- Staff Health & Compliance
- Services
- Deployment
- On-Cloud
- On-Premise
- End-User
- Hospital
- Laboratories
- Long-Term Care Facility
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Infection Surveillance Solution Market, by Product
- Infection Surveillance Solution Market, by Deployment
- Infection Surveillance Solution Market, by End-User
- Americas Infection Surveillance Solution Market
- Asia-Pacific Infection Surveillance Solution Market
- Europe, Middle East & Africa Infection Surveillance Solution Market
- Competitive Landscape
- Competitive Portfolio
- List of Figures [Total: 22]
- List of Tables [Total: 640]
- List of Companies Mentioned [Total: 31]
Understanding Infection Surveillance Solution:
Infection Surveillance Solution is a software system that tracks and analyzes patient data to identify and prevent the spread of infections in hospitals. The system is designed to manage patient data, monitor infections, and alert healthcare professionals when there is a potential outbreak. The technology analyses real-time data and identifies patterns and trends to improve patient outcomes and minimize infection spread. With Infection Surveillance Solution, healthcare facilities can quickly identify outbreaks and take necessary actions to mitigate their spread.
Benefits of Infection Surveillance Solution:
Infection Surveillance Solution provides numerous benefits to healthcare facilities. Firstly, it ensures patient safety by reducing the risk of acquiring infections during hospital stays. It also helps healthcare professionals to monitor and track infections, which allows for early detection and timely intervention. Moreover, Infection Surveillance Solution helps hospital administrators to identify high-risk units and implement preventative measures.
In addition, the solution provides real-time data on infections, which can help hospitals to improve their infection control strategies. It also simplifies data management and helps healthcare professionals to generate reports quickly and accurately. With these benefits, Infection Surveillance Solution allows hospitals to stay ahead of the curve regarding infection control.
How Infection Surveillance Solution Helps Hospitals:
In infection control, timing is critical. With Infection Surveillance Solution, hospitals can monitor patients in real time and identify infections promptly. This allows for early intervention, reducing the risk of complications and improving patient outcomes. The solution helps healthcare facilities identify outbreaks quickly and prevent them from spreading from one patient to another.
In addition, Infection Surveillance Solution helps healthcare professionals to manage data effectively. The solution provides efficient and automated data management, which reduces the chances of errors and saves healthcare professionals time. This data also helps hospital administrators to track disease patterns and improve hospital infection control strategies.
Implementing Infection Surveillance Solution:
Implementing an Infection Surveillance Solution requires a comprehensive approach that involves collaboration between hospital administrators, infection control specialists, and healthcare professionals. The process begins with identifying the hospital’s needs and selecting the appropriate solution based on the facility’s specific requirements.
Once the solution is identified, the next step is to implement it throughout the hospital. This involves training healthcare professionals on how to use the system and establishing policies and procedures to ensure that the system is used effectively. The process also includes monitoring the system’s performance, generating reports, and continuously improving infection control strategies.
Infection Surveillance Solution is a critical tool for hospitals in managing and preventing the spread of HAIs. The system provides real-time data that enables healthcare professionals to identify outbreaks quickly and take necessary actions to prevent their spread. It also streamlines data management and report generation, making it easier for hospitals to continually improve their infection control strategies. With proper implementation and usage, Infection Surveillance Solution is effective in reducing infections, increasing patient safety, and improving healthcare outcomes.
- How big is the Infection Surveillance Solution Market?
- What is the Infection Surveillance Solution Market growth?
- When do I get the report?
- In what format does this report get delivered to me?
- How long has 360iResearch been around?
- What if I have a question about your reports?
- Can I share this report with my team?
- Can I use your research in my presentation?